Quick access for journalists to up-to-date company information.
The RE-COVER™ trial results shed light on an important indication for anticoagulation: Acute Venous Thromboembolism.
Hypoactive Sexual Desire Disorder (HSDD) and its impact on women's life.
Compilations of the most relevant documents, images, videos and interesting links.
Corporate Headquarters Binger Str. 173 55216 Ingelheim Germany
Phone +49 / 6132 / 77 0 Fax +49 / 6132 / 72 0